Nevro’s HFX iQ Rückenmarkstimulation with AI Technology has achieved CE certification in Europe and improved the global product range

• Indication-specific HFX algorithm for back and spinal injuries, non-surgical treatment-resistant back injuries, severe diabetic neuropathy, chronic injuries in the upper Gliedmaßen and in nacken.

• Individual experiences with the therapy passage, which relate to the patient in the HFX app.

• The only 10 kHz therapy has a CE mark for all specific SCS indications and concerns about the Schmerzlinderung that can be used.

“With HFX iQ we are entering a new era in patient orientation treatments,” says Prof. Faycal El MajdoubLeader of Stereotaxy and Functional Neurosurgery in Krankenhaus Köln-Merheim. “The technology responds to individual Schmerz levels and goes beyond Echtzeit and the Bedürfnisse of Patients and, it was said, that the Patients were on their way to the best care. The patients have an improved quality of life with few, soft drinks are their lives with a view to and little Abhängigkeit of clinical a Eingriffen zurückerobern können. HFX iQ was clearly new, it was a long-awaited Schmerzlinderung-möglich ist.”

HFX iQ starts with the program, there is a Schmerzlinderung beetet and uses the HFX algorithm, which has more than 20 million data points and 80,000 implantable patients.¹ HFX iQ combines clinical assessment, with Schmerzlinderung and Schmerzbewertung, with Eingaben zur Lebensqualität (Quality of Life, QoL) with Schmerzmittel and the functioning of the active levels, an individual program setting for your patients for ermöglichen.² HFX iQ cannot be more common than Nevro’s proprietary 10 kHz Therapy programs and offers the widest bandwidth and frequency of the SCS system on the market.

The Senza HFX iQ system offers the best choice of the implantable HFX iQ pulse generator (IPG), the HFX test stimulator and the HFX app. With a new Bluetooth®-enabled IPG, which is activated and used directly with the HFX app, the patient can be given the opportunity to use their smartphone and then put it in the real programs.

Zusätzlich zur CE-Kennzeichnung erhielt HFX iQ 2022 the Zulassung of the US-American Food and Drug Administration (FDA).

The HFX iQ system will not be available in European states until 2025.

More information about HFX iQ can be found at http://nevro.com/German/arzte/Product-HFX-iQ.

Verweise

* The HFX iQ algorithm is a high-level program system, which can set the therapeutic effect and perform the role of the Arztes very well.

1. Patients use a Senza, Senza II or Omnia device with 10 kHz therapy.

Availability of information on the Internet

Nevro is regularly provided with information, which can be found on the website of investors and potential investors, on the website under www.nevro.com. These regular investors and potential investors, regularly consult the website on Nevro, with important information on Nevro. erhalten.

Uber Nevro

Nevro hat seinen Hauptsitz in Redwood City, California, and is a weltweit-tätiges Unternehmen für Medizinprodukte, that is ich der Bereitstellung umfassender, lebensverändernder Lösungen versschrieben hat, which still new maßstäbe for nachhaltige Behandlungsergebnisse in chronic Schmerzen setzen. The research started with the lonely Soul, more patients with strong Schmerzen their halves, and their own strengthening 10 kHz therapy, an evidentiary, non-pharmacological innovation, which is Life of more than 115,000 patients on the geese World changes hat. The umfassending HFX platform for the Rückenmarkstimulation (SCS) from Nevro umfasst the Senza SCS system and support services for the treatment of chronic Schmerzen in the body and in the Gliedmaßen that cause schmerzhna diabetic Neuropathy.

There is no minimally invasive treatment option available for patients in the room USA a perpetual Schmerzen in Iliosakralgelenk (“IS-Gelenk”) lead, and now the converted product portfolio is in the possession of the ISG-Gelenkfusion, which is on the Präferenzen of Ärzten and the uninterested Bedürfnisse of Patienten-zugeschnitten, um die Ensure that you get a good quality of life for the patient.

Senza, Senza II, Senza Omnia and HFX iQ are together with the unique SCS system, which supports Nevro therapy at 10 kHz. Nevro’s unified support services put your patients together with Schmerztherapie, an HFX Coach on their page and provide your Arzt with the knowledge of Nevrocloud™ for improved patient and practice management.

SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, from HFX Access-Logo, HFX COACH, from HFX Coach-Logo, Nevrocloud, RELIEF MULTIPLIED, HFX AdaptivAI, the Patent for Senza HFX iQ and other Nevro products at Nevro.com/patents aufgeführt . Bluetooth^® and the Bluetooth symbol is a mark with its own characteristics.

Wen Sie more about your current situation, see our LinkedIn, XFacebook and Instagram.

Investors and Media:

Angie McCabe
Vice President Investor Relations & Corporate Communications
[email protected]

Photo – https://mma.prnewswire.com/media/2554312/HFX_iQ_Hero_Shot_2.jpg
Logo – https://mma.prnewswire.com/media/466682/5017643/Nevro_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/de/pressemitteilungen/die-hfx-iq-ruckenmarkstimulation-von-nevro-mit-ki-technologie-erhalt-die-ce-zertifizierung-in- europe -and-the-global-product-palette-302301646.html